Related Experiment Video
Updated: Jun 11, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling
Mohammad Rasouli1, Mana Alavi1, Alberto D'Angelo2
1Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran.
Abstract:
Current cancer therapeutic strategies for the treatment of cancer are often unsuccessful due to unwanted side effects and drug resistance. Therefore, the design and development of potent, new anticancer platforms, such as stem-cell treatments, have attracted much attention. Distinctive biological properties of stem cells include their capacity to secrete bioactive factors, their limited immunogenicity, and their capacity for renewing themselves. Mesenchymal stem cells (MSCs) are one of several kinds of stem cells that are conveniently extracted and are able to be cultivated in vitro utilizing various sources. The secretome of stem cells contains many trophic factors, including cytokines, chemokines, growth factors, and microRNA molecules that can either promote or inhibit the formation of tumors, based on the cell environment. In the current review, we focused on the secretome of mesenchymal stem cells. These stem cells act as a double-edged sword in the regulation of cell signal transduction pathways in that they can either suppress or promote tumors.
Insights
Mesenchymal stem cells (MSCs) offer a novel anticancer platform due to their unique properties. Their secretome can either promote or inhibit tumor growth, acting as a double-edged sword in cancer therapy.
Area of Science:
- Oncology
- Stem Cell Biology
- Biotechnology
Background:
- Current cancer therapies face challenges with side effects and drug resistance.
- Stem cell-based treatments are emerging as promising anticancer platforms.
- Mesenchymal stem cells (MSCs) possess unique biological properties, including self-renewal and low immunogenicity.
Purpose of the Study:
- To review the role of mesenchymal stem cell (MSC) secretome in cancer.
- To explore the dual role of MSC secretome in tumor regulation.
- To highlight MSCs as a potential anticancer therapeutic strategy.
Main Methods:
- Review of current literature on MSC secretome and cancer.
- Analysis of bioactive factors secreted by MSCs.
- Examination of signaling pathways influenced by MSC secretome.
Main Results:
- MSC secretome contains trophic factors like cytokines, chemokines, and microRNAs.
- These factors can exhibit context-dependent effects on tumor growth.
- MSCs can act as a double-edged sword, either suppressing or promoting tumors.
Conclusions:
- The MSC secretome presents a complex but potent therapeutic avenue for cancer treatment.
- Understanding the tumor microenvironment is crucial for harnessing MSCs' anticancer potential.
- Further research into MSC secretome modulation is warranted for effective cancer therapy.
Related Concept Videos
Mesenchymal Stem Cells
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Niche

